# Zimmer Biomet to acquire Paragon 28 for $1.2B

Zimmer Biomet announced a definitive agreement to acquire Paragon 28 for an upfront payment of $13.00 per share, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion.

- Type: Acquisition
- Announced: 2025-01-28
- Where: United States
- Value: $1.20B
- Status: announced
- Products: foot and ankle orthopedic devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Zimmer Biomet](https://endata.com/companies/30687.md) (acquirer)
- [Paragon 28](https://endata.com/companies/55527.md) (target)

## Sources

- [investor.zimmerbiomet.com](https://investor.zimmerbiomet.com/news-and-events/news/2025/01-28-2025-225939148), 2025-01-28: "Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1"
- [health.economictimes.indiatimes.com](https://health.economictimes.indiatimes.com/news/medical-devices/zimmer-biomet-to-buy-paragon-28-for-1-1-billion/117669072), 2025-01-29: "Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices."
- [sec.gov](https://www.sec.gov/Archives/edgar/data/1531978/000095015725000076/form8-k.htm), 2025-01-29: "On January 28, 2025, Paragon 28, Inc. issued a press release announcing the entry into an Agreement and Plan of Merger with Zimmer, Inc."
- [paragon28.com](https://paragon28.com/zimmer-biomet-announces-definitive-agreement-to-acquire-paragon-28/), 2025-02-12: "This proposed transaction further diversifies Zimmer Biomet’s portfolio outside of core orthopedics and positions us well in one of the highest growth specialized segments in musculoskeletal care"
- [streetinsider.com](https://www.streetinsider.com/Business+Wire/Paragon+28+Announces+Expiration+of+HSR+Act+Waiting+Period+for+Pending+Acquisition+by+Zimmer+Biomet+Under+HSR+Act/24484565.html), 2025-03-11: "The expiration of the waiting period under the HSR Act represents a significant milestone in the regulatory approval process."
- [index.businessinsurance.com](https://index.businessinsurance.com/observerreporter/article/bizwire-2025-3-11-paragon-28-announces-expiration-of-hsr-act-waiting-period-for-pending-acquisition-by-zimmer-biomet-under-hsr-act), 2025-03-11: "The expiration of the waiting period under the HSR Act represents a significant milestone in the regulatory approval process, satisfying one of the conditions required to complete the proposed merger with Zimmer Biomet."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.